Status:
COMPLETED
Adding Ketamine to Levobupivacaine in Paravertebral Block in Thoracotomy
Lead Sponsor:
Tanta University
Conditions:
Ketamine
Levobupivacaine
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
To evaluate the role of adding ketamine to levobupivacaine in PVB on acute and chronic pain in thoracotomy
Detailed Description
Several adjuvants have been added to them to enhance the effects of those blocks. Dexamethasone, morphine, dexmedetomidine, clonidine, ketamine, and magnesium sulphate are some of them. results are va...
Eligibility Criteria
Inclusion
- Age 18-75 years.
- Both sexes.
- ASA (American Society of Anesthesiology) physical status II-III.
- Scheduled for open thoracotomy.
Exclusion
- Contraindications to or failed paravertebral block .
- Body mass index (BMI) \>35 kg/m2.
- The likelihood of postoperative mechanical ventilation.
- Patients with coagulopathy, poorly controlled diabetes mellitus, depression or other psychiatric disorders that required antidepressant drugs, alcohol, or recreational drug addiction.
- Hypersensitivity to ketamine or levobupivacaine.
Key Trial Info
Start Date :
August 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 26 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06011746
Start Date
August 30 2023
End Date
January 26 2024
Last Update
February 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University
Tanta, El-Gharbia, Egypt, 31527